<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">83628</article-id><article-id pub-id-type="doi">10.7554/eLife.83628</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Evolutionary Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>Hierarchical sequence-affinity landscapes shape the evolution of breadth in an anti-influenza receptor binding site antibody</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-293362"><name><surname>Phillips</surname><given-names>Angela M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9806-7574</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-295784"><name><surname>Maurer</surname><given-names>Daniel P</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-295785"><name><surname>Brooks</surname><given-names>Caelan</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-243887"><name><surname>Dupic</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-295787"><name><surname>Schmidt</surname><given-names>Aaron G</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-40694"><name><surname>Desai</surname><given-names>Michael M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9581-1150</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-6"/><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf3"/></contrib><aff id="aff1"><institution content-type="dept">1Department of Organismic and Evolutionary Biology</institution>, <institution>University of California, San Francisco</institution>, <addr-line><named-content content-type="city">San Francisco</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Microbiology</institution>, <institution>Harvard Medical School</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Department of Physics</institution>, <institution>Harvard University</institution>, <addr-line><named-content content-type="city">Cambridge, MA</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Department of Organismic and Evolutionary Biology</institution>, <institution>Harvard University</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-61967"><name><surname>Kurosaki</surname><given-names>Tomohiro</given-names></name><role>Reviewing editor</role><aff><institution>Osaka University</institution>, <country>Japan</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>angela.phillips@ucsf.edu</email> (AP);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>mdesai@oeb.harvard.edu</email> (MD);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>10</day><month>01</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e83628</elocation-id><history><date date-type="received"><day>21</day><month>09</month><year>2022</year></date><date date-type="accepted"><day>09</day><month>01</month><year>2023</year></date></history><permissions><copyright-statement>Â© 2023, Phillips et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Phillips et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-83628-v1.pdf"/><abstract><p>Broadly neutralizing antibodies (bnAbs) that neutralize diverse variants of a particular virus are of considerable therapeutic interest<sup>1</sup>. Recent advances have enabled us to isolate and engineer these antibodies as therapeutics, but eliciting them through vaccination remains challenging, in part due to our limited understanding of how antibodies evolve breadth<sup>2</sup>. Here, we analyze the landscape by which an anti-influenza receptor binding site (RBS) bnAb, CH65, evolved broad affinity to diverse H1 influenza strains<sup>3,4</sup>. We do this by generating an antibody library of all possible evolutionary intermediates between the unmutated common ancestor (UCA) and the affinity-matured CH65 antibody and measure the affinity of each intermediate to three distinct H1 antigens. We find that affinity to each antigen requires a specific set of mutations - distributed across the variable light and heavy chains - that interact non-additively (<italic>i.e.</italic>, epistatically). These sets of mutations form a hierarchical pattern across the antigens, with increasingly divergent antigens requiring additional epistatic mutations beyond those required to bind less divergent antigens. We investigate the underlying biochemical and structural basis for these hierarchical sets of epistatic mutations and find that epistasis between heavy chain mutations and a mutation in the light chain at the V<sub>H</sub>-V<sub>L</sub> interface is essential for binding a divergent H1. Collectively, this work is the first to comprehensively characterize epistasis between heavy and light chain mutations and shows that such interactions are both strong and widespread. Together with our previous study analyzing a different class of anti-influenza antibodies<sup>5</sup>, our results implicate epistasis as a general feature of antibody sequence-affinity landscapes that can potentiate and constrain the evolution of breadth.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>S. cerevisiae</italic></kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000011</institution-id><institution>Howard Hughes Medical Institute</institution></institution-wrap></funding-source><award-id>Hanna H. Gray Postdoctoral Fellowship</award-id><principal-award-recipient><name><surname>Phillips</surname><given-names>Angela M</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000854</institution-id><institution>Human Frontier Science Program</institution></institution-wrap></funding-source><award-id>Postdoctoral Fellowship</award-id><principal-award-recipient><name><surname>Dupic</surname><given-names>Thomas</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01AI146779</award-id><principal-award-recipient><name><surname>Schmidt</surname><given-names>Aaron G</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>P01AI89618-A1</award-id><principal-award-recipient><name><surname>Schmidt</surname><given-names>Aaron G</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000001</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source><award-id>DMS-1764269</award-id><principal-award-recipient><name><surname>Desai</surname><given-names>Michael M</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000001</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source><award-id>DMS-1655960</award-id><principal-award-recipient><name><surname>Desai</surname><given-names>Michael M</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>GM104239</award-id><principal-award-recipient><name><surname>Desai</surname><given-names>Michael M</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Angela M Phillips, has recently consulted for Leyden Labs..</p></fn><fn fn-type="conflict" id="conf3"><p>Michael M Desai, recently consulted for Leyden Labs..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Data and code used for this study are available at https://github.com/amphilli/CH65-comblib. Antibody affinity and expression data are also available in an interactive data browser at https://ch65-ma90-browser.netlify.app/. FASTQ files from high-throughput sequencing are deposited in the NCBI BioProject database under PRJNA886089. X-ray crystal structures of the Fabs reported here are available at the Protein Data Bank (8EK6 and 8EKH).</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Phillips AM</collab><collab>Maurer DP</collab><collab>Brooks C</collab><collab>Dupic T</collab><collab>Schmidt AG</collab><collab>Desai MM</collab></person-group><year iso-8601-date="2022">2022</year><source>Binding affinity landscape of CH65 to divergent influenza H1 strains</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA886089/">https://www.ncbi.nlm.nih.gov/bioproject/PRJNA886089/</ext-link><comment>NCBI BioProject, PRJNA886089</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Phillips AM</collab><collab>Maurer DP</collab><collab>Brooks C</collab><collab>Dupic T</collab><collab>Schmidt AG</collab><collab>Desai MM</collab></person-group><year iso-8601-date="2022">2022</year><source>CH65 Tite-Seq KD Measurements</source><ext-link ext-link-type="uri" xlink:href="https://ch65-ma90-browser.netlify.app">https://ch65-ma90-browser.netlify.app</ext-link><comment>CH65 online data browser</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-83628-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>